Revolution Medicines News - RVMD

Company Name	Stock Ticker Symbol	Market	Type
Revolution Medicines Inc	RVMD	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.18	0.49%	36.61	12:47:04

Open Price	Low Price	High Price	Close Price	Prev Close
36.45	36.17	37.87		36.43

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	15:34	GLOBE	Revolution Medicines Announces Publication on the Discovery..
4/08/2024	11:36	GLOBE	Revolution Medicines Announces Publications on the Discovery..
4/04/2024	16:05	GLOBE	Revolution Medicines to Participate in Upcoming Investor..
3/28/2024	16:05	GLOBE	Revolution Medicines to Deliver Multiple Presentations at..
3/05/2024	16:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:23	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2/26/2024	17:04	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/26/2024	16:05	GLOBE	Revolution Medicines Reports Fourth Quarter and Full Year..
2/26/2024	16:04	EDGAR2	Form 8-K - Current report
2/20/2024	16:05	GLOBE	Revolution Medicines to Report Financial Results for Fourth..
2/09/2024	17:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/01/2024	16:05	GLOBE	Revolution Medicines to Participate in Upcoming Investor..
1/24/2024	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/22/2024	16:18	EDGAR2	Form 144 - Report of proposed sale of securities
1/09/2024	14:15	EDGAR2	Form 8-K - Current report
1/04/2024	07:00	GLOBE	Revolution Medicines to Present at 42nd Annual J.P...
12/20/2023	17:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/14/2023	18:22	EDGAR2	Form 144 - Report of proposed sale of securities
12/14/2023	17:48	EDGAR2	Form 144 - Report of proposed sale of securities
11/20/2023	18:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/20/2023	16:14	EDGAR2	Form 144 - Report of proposed sale of securities
11/16/2023	14:58	EDGAR2	Form CERT - Certification by an exchange approving..
11/15/2023	16:04	EDGAR2	Form 8-A12B - Registration of securities [Section 12(b)]
11/14/2023	20:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/14/2023	20:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/14/2023	20:13	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/09/2023	09:20	EDGAR2	Form 8-K - Current report
11/09/2023	09:10	GLOBE	Revolution Medicines Completes Acquisition of EQRx
11/08/2023	11:30	GLOBE	Revolution Medicines and EQRx Stockholders Approve EQRx..
11/06/2023	16:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/2023	16:05	GLOBE	Revolution Medicines Reports Third Quarter 2023 Financial..
11/06/2023	16:05	EDGAR2	Form 8-K - Current report
11/01/2023	07:15	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/01/2023	07:11	EDGAR2	Form 425 - Prospectuses and communications, business..
11/01/2023	07:08	EDGAR2	Form 8-K - Current report
11/01/2023	07:00	GLOBE	Leading Independent Proxy Advisory Firms ISS and Glass Lewis..
10/31/2023	16:15	GLOBE	Revolution Medicines to Report Financial Results for Third..
10/23/2023	18:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/23/2023	06:13	EDGAR2	Form 425 - Prospectuses and communications, business..
10/23/2023	06:11	EDGAR2	Form 8-K - Current report
10/22/2023	02:30	GLOBE	Revolution Medicines Presents Promising Clinical Activity..
10/13/2023	11:54	EDGAR2	Form 8-K - Current report
10/13/2023	11:50	GLOBE	Revolution Medicines Presents Encouraging Clinical Data for..
10/04/2023	16:05	GLOBE	Revolution Medicines to Present New Clinical Data at Major..
10/02/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/29/2023	16:19	EDGAR2	Form DEFM14A - Definitive proxy statement relating to merger..
9/29/2023	16:17	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]